Nallengare Pharmaceuticlas Pvt Ltd
Founded in 1983 and headquartered in Kerala, India.
1983 | Thrissur, Kerala (India) | Active
Nallengare Pharmaceuticlas Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 41 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.87 M
- Revenue Growth 0.58%
- Profit Growth 26.63%
- Ebitda -2.54%
- Net Worth -28.83%
- Total Assets 0.84%
About Nallengare Pharmaceuticlas
Nallengare Pharmaceuticlas Pvt Ltd (NPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 1983 and has a history of 41 years and eight months. Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.87 M.
Milly Varghese and Paul Varghese serve as directors at the Company.
Company Details
- Location
Thrissur, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231KL1983PTC003760
- Company No.
003760
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Chemicals
Nallengare Pharmaceuticlas Pvt Ltd
Explore comprehensive data for Nallengare Pharmaceuticlas Pvt Ltd, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Nallengare Pharmaceuticlas?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paul Varghese  | Managing Director | 28-Sep-2010 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Milly Varghese | Director | 21-Jul-1983 | Current |
Financial Performance of Nallengare Pharmaceuticlas.
Nallengare Pharmaceuticlas Pvt Ltd, for the financial year ended 2017, experienced modest growth in revenue, with a 0.58% increase. The company also saw a substantial improvement in profitability, with a 26.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nallengare Pharmaceuticlas?
In 2017, Nallengare Pharmaceuticlas had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Roterende Properties Private Limited
Paul Varghese is a mutual person
Charges (Loans)
Open Charges
₹0.87 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Sampanna Kuries (P) Ltd : 0.05 Cr
- Gampanra Furies (I) Ltd : 0.02 Cr
- South Indian Bank Ltd : 0.01 Cr
- The South Indian Bank Limited : 0.01 Cr
- Federal Bank Ltd : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Mar 2001 | Sampanna Kuries (P) Ltd | ₹0.46 M | Open |
| 12 Jul 1988 | Gampanra Furies (I) Ltd | ₹0.18 M | Open |
| 18 Dec 1986 | Federal Bank Ltd | ₹0.02 M | Open |
| 29 Apr 1986 | South Indian Bank Ltd | ₹0.12 M | Open |
| 26 Oct 1984 | The South Indian Bank Limited | ₹0.10 M | Open |
How Many Employees Work at Nallengare Pharmaceuticlas?
Unlock and access historical data on people associated with Nallengare Pharmaceuticlas, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nallengare Pharmaceuticlas, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nallengare Pharmaceuticlas's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nallengare Pharmaceuticlas
Recent activity within the organization
- Annual General Meeting
Nallengare Pharmaceuticlas Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nallengare Pharmaceuticlas Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam.
- Director Appointment
Paul Varghese was appointed as a Managing Director was appointed as a Managing Director on 28 Sep 2010 & has been associated with this company since 14 years 5 months .
- Charges
A charge with Sampanna Kuries (P) Ltd amounted to Rs. 0.46 M with Charge ID 90018148 was registered on 01 Mar 2001.
- Charges
A charge with Gampanra Furies (I) Ltd amounted to Rs. 0.18 M with Charge ID 90015677 was registered on 12 Jul 1988.
- Charges
A charge with Federal Bank Ltd amounted to Rs. 0.02 M with Charge ID 90015589 was registered on 18 Dec 1986.
Frequently asked questions
What is the Incorporation or founding date of Nallengare Pharmaceuticlas Pvt Ltd?
Nallengare Pharmaceuticlas Pvt Ltd was incorporated on 21 Jul 1983.
What is authorized share capital and paid-up capital of Nallengare Pharmaceuticlas Pvt Ltd?
The authorized share capital of Nallengare Pharmaceuticlas Pvt Ltd is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Nallengare Pharmaceuticlas Pvt Ltd?
Currently 2 directors are associated with Nallengare Pharmaceuticlas Pvt Ltd.
- Milly Varghese
- Paul Varghese
What is the registered address of Nallengare Pharmaceuticlas Pvt Ltd?
As per Ministry of Corporate Affairs (Mca), the registered address of Nallengare Pharmaceuticlas Pvt Ltd is Xi/336Caico Road Ollur India, Trichur, Kerala, 680006.
What is the corporate identification number (CIN) and company number of Nallengare Pharmaceuticlas Pvt Ltd?
The corporate identification number (CIN) of Nallengare Pharmaceuticlas Pvt Ltd is U24231KL1983PTC003760 and the company number is 003760 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Nallengare Pharmaceuticlas Pvt Ltd?
According to the financial reports for the fiscal year 2017, the revenue trend for Nallengare Pharmaceuticlas Pvt Ltd has risen by 0.58%.
What change has been observed in the net worth of Nallengare Pharmaceuticlas Pvt Ltd, and by what percentage?
The financial reports for the fiscal year 2017 indicates that The net worth of Nallengare Pharmaceuticlas Pvt Ltd has experienced an downturn of -28.83%.
What are the total open charges for Nallengare Pharmaceuticlas Pvt Ltd?
As per the financial statements for fiscal Year 2017, The total open charges for Nallengare Pharmaceuticlas Pvt Ltd amount to ₹ 0.87 M.
When was the last Balance Sheet of Nallengare Pharmaceuticlas Pvt Ltd filed with the ROC?
The most recent Balance Sheet for Nallengare Pharmaceuticlas Pvt Ltd was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
NP
Nallengara PaulManaging Director